USs stocks rose on Monday, with Alphabet driving a broader rebound as the market attempted to stabilise after a sharp November decline driven by fading enthusiasm for artificial intelligence stocks. M... ...

Iberdrola has announced a public tender offer for the remaining 16.2% of its Brazilian subsidiary Neoenergia, hoping to achieve 100% ownership of the company. The Spanish electricity group already own... ...

Palantir stock (NASDAQ: PLTR) nosedived 25% after reaching an all-time high in early November, triggering a fiery public clash between CEO Alex Karp and hedge fund manager Michael Burry. Karp blamed s... ...

Core Insights - Gold prices experienced a decline on Monday, attributed to a stronger dollar against a basket of major currencies [1] - Silver prices also saw a slight decrease, influenced by the strengthening dollar which negatively impacted market sentiment [1] Group 1 - The strengthening of the dollar is a key factor affecting gold prices [1] - The decline in silver prices is also linked to the dollar's performance [1]

Core Insights - The S&P 500 Index experienced significant volatility due to reactions to Federal Reserve officials' statements, Nvidia's earnings report, and the ongoing cryptocurrency market crash [1] Group 1: Market Reactions - Market participants showed heightened volatility in response to key statements from Federal Reserve officials [1] - Nvidia's earnings report was closely monitored, contributing to market fluctuations [1] - The ongoing cryptocurrency market crash added to the overall market instability [1]

Shares of Novo Nordisk fell sharply on Monday after the company announced that a high-profile trial testing whether its oral semaglutide medicine could slow the progression of Alzheimer's disease had ... ...

On Monday, investors urged BHP to drop its pursuit of Anglo American and instead focus on its established growth strategy. This advice comes after the Australian firm's recent, last-ditch effort to a... ...

Core Viewpoint - Bayer shares experienced a significant increase following positive late-stage clinical trial results for its experimental cardiovascular drug asundexian, marking a rare positive development for its pharmaceutical division, which has faced challenges and rising litigation costs [1] Group 1 - Bayer's stock rose over 9%, reaching €30.30, the highest level in over a week [1]

Core Insights - The FTSE 100 Index has experienced significant pressure recently due to heightened volatility in global stocks [1] - The index fell to a low of £9,540, representing a decline of over 4% from its peak this year [1] Market Performance - The FTSE 100 Index's recent low indicates a challenging market environment for investors [1] - The decline reflects broader trends in global stock markets, suggesting a potential shift in investor sentiment [1]

Singapore's DBS Group has adjusted its expansion move in Malaysia by submitting a fresh request to acquire a smaller stake in Alliance Bank Malaysia. The filing, made after the first application was n... ...